Are toxic chemicals going out of fashion?

| April 23, 2019

article image
Even though the oil industry is far from finished – and the term peak oil seems, at least for the time being, to have gone out of fashion due to fracking – I doubt many people would call it a sector with a bright outlook.Serving as a perfect example of this is the Norwegian oil fund, one of the world’s largest funds, which manages the revenue from Norway’s oil and gas resources. Somewhat ironically, it announced a month ago that it would sell its oil and gas holdings. “It’s about lowering the risks”, Norway’s Minister of Finance explained.

Spotlight

Zydus Pharmaceuticals USA, Inc.

Zydus Pharmaceuticals (USA) Inc. is located in Pennington, NJ, and is the U.S. division of Cadila Healthcare. Since our first commercial launch in August of 2005, we have grown steadily and are now one of the top 10 U.S. generic companies in total prescriptions dispensed. We are also proud to note that since 2005 we have been recognized annually by IMS Health as one of the fastest growing pharmaceutical companies in the U.S. Zydus is focused on providing outstanding customer service, along with high-quality, affordable generic products to our customers and their patients. Zydus is a vertically integrated generic pharmaceutical company. We manufacture over 50% of our product’s active pharmaceutical ingredient (API) and in fact take it a few steps further by even manufacturing our own bottles. This allows us to ensure and maintain our excellent supply record to our customers. We have also already completed 2D bar-coding on all of our manufactured products to meet the future pedigree requ

OTHER ARTICLES

Global polyolefins for the rest of 2021: supply to lengthen as demand muddle continues

Article | May 2, 2021

SOMEHOW, despite the still very serious container freight shortages that have limited imports, buying sentiment seems to have weakened in the European polyolefins market, according to my outstanding ICIS colleague, Linda Naylor.

Read More

How Is the SCIP Database Different From the REACH Regulation

Article | February 14, 2020

Companies operating in the European Union (EU) must submit data when introducing articles containing Substances of Very High Concern (SVHCs) above the 0.1 percent weight by weight (w/w) threshold. The reporting trigger for an in-scope article is currently derived from the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Regulation’s Candidate List of SVHCs, but the data requirements for the SCIP database, triggered by the EU Waste Framework Directive (WFD), vary widely from those required by the REACH Regulation.

Read More

Taiwan Amends the Toxic Chemical Substance Operators Liability Insurance Measures

Article | March 1, 2020

Taiwan amended the Toxic Chemical Substances Operation Liability Insurance Measures and renamed it the Toxic and Concerned Chemical Substance Operators Liability Insurance Measures. The Measures require operators to obtain liability insurance before operation if the total amount during the manufacture, use, storage, and transportation of toxic chemicals of the first to third categories or hazardous chemical substances of concern reach a specified benchmark.

Read More

Pulmonary toxicity – a challenge for drug and chemical development

Article | March 11, 2020

Despite the common assumption that adverse drug reactions only affect the kidney and liver, more than 600 medications inducing lung toxicity have been reported.1 Lungs are susceptible to toxicity due to their large surface area and metabolism of certain substances2, such as antibiotics and anti-inflammatories, and specialist drugs targeting the cardiovascular system and tumours. This has resulted in 4-10% of patients developing pulmonary toxicity.

Read More

Spotlight

Zydus Pharmaceuticals USA, Inc.

Zydus Pharmaceuticals (USA) Inc. is located in Pennington, NJ, and is the U.S. division of Cadila Healthcare. Since our first commercial launch in August of 2005, we have grown steadily and are now one of the top 10 U.S. generic companies in total prescriptions dispensed. We are also proud to note that since 2005 we have been recognized annually by IMS Health as one of the fastest growing pharmaceutical companies in the U.S. Zydus is focused on providing outstanding customer service, along with high-quality, affordable generic products to our customers and their patients. Zydus is a vertically integrated generic pharmaceutical company. We manufacture over 50% of our product’s active pharmaceutical ingredient (API) and in fact take it a few steps further by even manufacturing our own bottles. This allows us to ensure and maintain our excellent supply record to our customers. We have also already completed 2D bar-coding on all of our manufactured products to meet the future pedigree requ

Events